Bridgeway Capital Management’s Biote BTMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$41.6K Sell
34,401
-599
-2% -$1.06K ﹤0.01% 1198
2026
Q2
$66.2K Sell
35,000
-18,358
-34% -$37.8K ﹤0.01% 1183
2026
Q1
$72K Sell
53,358
-50,000
-48% -$100K ﹤0.01% 1164
2025
Q4
$269K Sell
103,358
-17,695
-15% -$48.4K 0.01% 959
2025
Q3
$363K Hold
121,053
– – 0.01% 873
2025
Q2
$487K Buy
121,053
+71,053
+142% +$262K 0.01% 782
2025
Q1
$166K Buy
+50,000
New +$238K ﹤0.01% 956

Other funds holding BTMD

Bridgeway Capital Management's BTMD Position: Q3 2026 in Review

Bridgeway Capital Management reduced its Biote (BTMD) stake by 1.7% in Q3 2026, selling an estimated $1.06K and leaving 34,401 shares worth $41.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1198.

Bridgeway Capital Management first reported a position in BTMD in Q1 2025 and has held it in 7 quarters since. The position peaked at $487K in Q2 2025. 52 funds tracked by Wall St. Rank hold BTMD as of Q3 2026.

  • Bridgeway Capital Management held 34,401 shares of Biote worth $41.6K as of Q3 2026.
  • Bridgeway Capital Management sold 599 Biote shares in Q3 2026, an estimated $1.06K.
  • Biote made up ﹤0.01% of Bridgeway Capital Management's portfolio in Q3 2026, its #1198 holding.
  • Bridgeway Capital Management first reported a position in Biote in Q1 2025 and has held it in 7 quarters since.
  • Bridgeway Capital Management's Biote position peaked at $487K in Q2 2025.
  • 52 funds tracked by Wall St. Rank held Biote as of Q3 2026.

Based on Bridgeway Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.